Lahore: Ferozsons Laboratories Limited convened its 70th Annual General Meeting on Wednesday, October 28, 2026, where shareholders approved several key resolutions including a final cash dividend and the reappointment of auditors.

The meeting, held in Lahore, confirmed the minutes from the Extraordinary General Meeting on July 3, 2026. The audited financial statements for the fiscal year ending June 30, 2026, were thoroughly reviewed and subsequently adopted by the attendees.

A significant decision taken during the meeting was the approval of a final cash dividend at a rate of 55%, translating to Rs. 5.5 per share, for the year ended June 30, 2026. This resolution was passed following the recommendation of the Board of Directors.

Additionally, the shareholders reappointed Messrs. KPMG Taseer Hadi & Co., Chartered Accountants, as the external auditors for the fiscal year ending June 30, 2027. The remuneration for the auditors was determined and approved by the Board of Directors.

In a special resolution, transactions with related parties, as detailed in note 39 of the unconsolidated financial statements for the year ended June 30, 2026, were ratified and confirmed.

According to information available from the Pakistan Stock Exchange (PSX), Ferozsons Laboratories Limited operates within the pharmaceutical sector, and such resolutions are standard practice to ensure compliance and transparency in financial dealings.

The AGM underscored Ferozsons Laboratories Limited’s commitment to maintaining robust financial practices and shareholder engagement through confirmed, audited, and well-documented corporate decisions.